from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0875c/-

LFCtreatmentdescriptionclass of inhibitor

-0.731

Amikacinug/mL Amikacintranslation

-0.930

Cap5-10ug/mL Capreomycintranslation

-1.008

Rox10-50 ug/mL Roxithromycintranslation

-0.803

SM2-5 ug/mL Streptomycintranslation

-1.519

Tet5-10 ug/mL Tetracyclinetranslation

0.294

Rif0.2-5ug/mL Rifampicintranscription

-0.367

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.629

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.255

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.494

CPZ10-50 ug/mL Chlorpromazinerespiration

1.004

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.021

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.503

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.767

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.274

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.046

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.272

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.196

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.885

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.135

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.584

KCN5-20 ug/mL Potassium cyaniderespiration

1.312

NaN30.2-2 mM Sodium aziderespiration

-0.573

Nigericin50 uM Nigericinrespiration

0.859

TRC10-150 ug/mL Triclosanrespiration

0.139

TRZ10-25 ug/mL Thioridazinerespiration

-1.785

Valinomycin0.5-10 uM Valinomycinrespiration

-0.647

ZnSO42 mM ZnSO4respiration

-0.469

menadione6-10 ug/mL Menadionerespiration

-0.183

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.058

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.093

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.085

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.407

NRP_1Non-replicating persistence stage 1dosRassociated

-0.541

Amp0.2mg/mL AmpicillincellWall

-0.135

Cephalexin20-100 ug/mL CephalexincellWall

-0.166

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.374

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.205

EMB10-20 ug/mL EthambutolcellWall

-0.418

Eta12-40 ug/mL EthionamidecellWall

-0.530

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.312

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.433

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.090

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.767

BZA0.12 mg/mL BenzamidearomaticAmides

0.128

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.244

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.646

H2O24 mM hydrogen peroxideDNAdamaging

-0.246

Levo10 ug/mL LevofloxacinDNAdamaging

-0.736

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.949

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.446

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.609

UVUV-irradiationDNAdamaging

-0.374

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.431

Antimycin12.5-50 ug/mL Antimycin A?

-0.098

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.196

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.388

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.783

PA8240.2-2 ug/mL PA-824?

2.537

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.522

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.170

Verapamil50 uM Verapamil?

-0.466

mercaptoethanol2 mM 2-Mercaptoethanol?

0.159

methoxatin10-20 ug/mL Methoxatin?